The present invention is directed to 2-amino-3,4-dihydro-quinoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of β-secretase, also known as β-site cleaving enzyme and BACE, BACE1, Asp2 and memapsin2.
本发明涉及2-
氨基-3,4-二
氢喹啉衍
生物、含有它们的药物组合物以及它们在治疗阿尔茨海默病(AD)和相关疾病中的应用。本发明的化合物是β-秘密酶的
抑制剂,也称为β-位点剪切酶和
BACE、
BACE1、Asp2和memapsin2。